DKCM
ELV icon

Davidson Kempner Capital Management’s Elevance Health ELV Stock Holding History

Davidson Kempner Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,050
Closed -$6.16M – 261
2026
Q1 		$6.16M Buy
+21,050
New +$6.92M 0.07% 135
2016
Q3 		– Sell
-24,789
Closed -$3.26M – 164
2016
Q2 		$3.26M Buy
+24,789
New +$3.39M 0.08% 131
2015
Q4 		– Sell
-12,880
Closed -$1.8M – 162
2015
Q3 		$1.8M Buy
+12,880
New +$1.94M 0.03% 138

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Davidson Kempner Capital Management's ELV Position: Q2 2026 in Review

Davidson Kempner Capital Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 21,050 shares — an estimated $6.16M sold.

Davidson Kempner Capital Management first reported a position in ELV in Q3 2015 and held it in 3 quarters. The position peaked at $6.16M in Q1 2026. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Davidson Kempner Capital Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 21,050 Elevance Health shares in Q2 2026, an estimated $6.16M.
  • Davidson Kempner Capital Management first reported a position in Elevance Health in Q3 2015 and held it in 3 quarters.
  • Davidson Kempner Capital Management's Elevance Health position peaked at $6.16M in Q1 2026.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.